Kurt D. Christensen, Megan Bell, Carrie L. B. Zawatsky, Lauren N. Galbraith, Robert C. Green, Allison M. Hutchinson, Leila Jamal, Jessica L. LeBlanc, Jennifer R. Leonhard, Michelle Moore, Lisa Mullineaux, Natasha Petry, Dylan M. Platt, Sherin Shaaban, April Schultz, Bethany D. Tucker, Joel Van Heukelom, Elizabeth Wheeler, Emilie S. Zoltick, Catherine Hajek, on behalf of the Imagenetics Metrics Team, Baye Jordan, Bell Megan, Deberg Kristen, Forred Benjamin, Free Colette, Hajek Catherine, Heukelom Joel Van, Hopp Ashley, Hutchinson Allison, Lees Ryne, Leonhard Jennifer, Massmann Amanda, Moore Michelle, Mroch Amelia, Petry Natasha, Platt Dylan, Royer Erin, Schultz April, Sincan Murat, Tucker Bethany, Wheeler Elizabeth, Christensen Kurt, Galbraith Lauren, LeBlanc Jessica, Walsh Ryan, Zoltick Emilie, Green Robert, Preys Charlene, Zawatsky Carrie, Mullineaux Lisa, Jamal Leila
Abstract
Genetic testing has the potential to revolutionize primary care, but few health systems have developed the infrastructure to support precision population medicine applications or attempted to evaluate its impact on patient and provider outcomes. In 2018, Sanford Health, the nation's largest rural nonprofit health care system, began offering genetic testing to its primary care patients. To date, more than 11,000 patients have participated in the Sanford Chip Program, over 90% of whom have been identified with at least one informative pharmacogenomic variant, and about 1.5% of whom have been identified with a medically actionable predisposition for disease. This manuscript describes the rationale for offering the Sanford Chip, the programs and infrastructure implemented to support it, and evolving plans for research to evaluate its real-world impact.
Pharmacology, Toxicology and Pharmaceutical Science
1
3%
Immunology and Microbiology
1
3%
Other
6
19%
Unknown
13
41%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2021.
All research outputs
#3,830,196
of 23,323,574 outputs
Outputs from Frontiers in Genetics
#1,183
of 12,335 outputs
Outputs of similar age
#94,318
of 423,345 outputs
Outputs of similar age from Frontiers in Genetics
#58
of 509 outputs
Altmetric has tracked 23,323,574 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,335 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 509 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.
